3,887.00
+4.52%
Close of 9 Nov 2026, in ILA
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sofwave Medical
Its shares trade on Tel Aviv under the ticker SOFW.TA. It has been listed since 18 May 2021. In the fiscal year to 31 December 2024, it reported revenue of $59.7m and a net loss of $4.5m. At that date it held total assets of $43.0m and shareholders' equity of $24.5m.
Sofwave Medical Ltd. engages in development, production, marketing, and sale of systems for skin rejuvenation and firming treatments. The firm operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The firm has subsidiary in United States -Sofwave Medical Inc.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 18 May 2021
- Website
- sofwave.com ↗
Leadership
Pay as last reported
- Mr. Assaf KornerChief Financial Officer
- Dr. Shimon EckhouseChairman of the Board, Co-Founder
- Mr. Louis ScafuriChief Executive Officer
- Mr. Ariel SverdlikCo-Founder, Chief Technology Officer
- Mr. Genady NahshonChief Operating Officer and Site Manager
- Ms. Lina OmariChief Digital Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Sofwave Medical Ltd. operates in the Health Care sector with a focus on skin rejuvenation technology.
- The company's SUPERB technology provides non-invasive skin tightening solutions for face and neck treatments.
- Sofwave Medical Inc. in the United States supports global market expansion and technical services.
Weaknesses
- The company's operations are limited to skin rejuvenation treatments without broader medical applications.
- Sofwave Medical Ltd. has no presence in the European market despite global expansion efforts.
- The firm's reliance on a single product line may limit diversification opportunities.
Opportunities
- Expanding into the United States market through Sofwave Medical Inc. offers significant growth potential.
- The Health Care sector's increasing demand for non-invasive treatments presents new market opportunities.
- Growing interest in skin rejuvenation technology in Asia could drive future revenue streams.
Threats
- Competition from established medical technology firms in the Health Care sector remains a challenge.
- Regulatory changes in the United States could impact the company's operations and market access.
- Economic downturns may reduce consumer spending on non-essential cosmetic procedures.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.